Biomarkers /

RSPO2

Back to Biomarkers List
Associated Diseases

Overview

Location [1]
8q23.1
Protein [2]
R-spondin-2
Synonyms [1]
CRISTIN2, HHRRD, TETAMS2

RSPO2 is altered in 0.44% of all cancers with melanoma, colon adenocarcinoma, lung adenocarcinoma, breast invasive ductal carcinoma, and invasive breast carcinoma having the greatest prevalence of alterations [3].

RSPO2 GENIE Cases - Top Diseases

The most common alterations in RSPO2 are RSPO2 Amplification (0.46%), RSPO2 Fusion (0.03%), RSPO2 M139V (0.06%), RSPO2 R64Q (0.05%), and RSPO2 V234I (0.05%) [3].

RSPO2 GENIE Cases - Top Alterations

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.